TA
CLDX icon

Teachers Advisors’s Celldex Therapeutics CLDX Stock Holding History

Teachers Advisors’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-67,373
Closed -$2.35M – 3061
2018
Q1 		$2.35M Buy
67,373
+42,519
+171% +$1.65M ﹤0.01% 1725
2017
Q4 		$1.06M Buy
24,854
+5,594
+29% +$240K ﹤0.01% 2206
2017
Q3 		$826K Buy
19,260
+55
+0.3% +$2.06K ﹤0.01% 2348
2017
Q2 		$712K Buy
19,205
+7,558
+65% +$334K ﹤0.01% 2426
2017
Q1 		$631K Buy
11,647
+475
+4% +$24.7K ﹤0.01% 2417
2016
Q4 		$593K Buy
11,172
+95
+0.9% +$5.4K ﹤0.01% 2446
2016
Q3 		$671K Buy
11,077
+81
+0.7% +$5.04K ﹤0.01% 2311
2016
Q2 		$724K Buy
10,996
+410
+4% +$26K ﹤0.01% 2217
2016
Q1 		$600K Sell
10,586
-17,530
-62% -$1.97M ﹤0.01% 2243
2015
Q4 		$6.61M Buy
28,116
+4,840
+21% +$1.06M 0.01% 1043
2015
Q3 		$3.68M Buy
23,276
+67
+0.3% +$19K 0.01% 1235
2015
Q2 		$8.78M Buy
23,209
+122
+0.5% +$48.5K 0.02% 954
2015
Q1 		$9.65M Buy
23,087
+9,161
+66% +$3.28M 0.02% 910
2014
Q4 		$3.81M Hold
13,926
– – 0.01% 1251
2014
Q3 		$2.71M Buy
13,926
+28
+0.2% +$6.1K 0.01% 1400
2014
Q2 		$3.4M Sell
13,898
-248
-2% -$56K 0.01% 1300
2014
Q1 		$3.75M Buy
14,146
+136
+1% +$52.1K 0.01% 1234
2013
Q4 		$5.09M Buy
14,010
+6,638
+90% +$2.56M 0.01% 1087
2013
Q3 		$3.92M Buy
7,372
+240
+3% +$82.3K 0.01% 1123
2013
Q2 		$1.67M Buy
+7,132
New +$1.4M ﹤0.01% 1524

Other funds holding CLDX

KE
KLP Enterprises Branford, Connecticut $1.97M AUM
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Teachers Advisors's CLDX Position: Q2 2018 in Review

Teachers Advisors sold out of Celldex Therapeutics (CLDX) in Q2 2018, closing a stake of 67,373 shares — an estimated $2.35M sold.

Teachers Advisors first reported a position in CLDX in Q2 2013 and held it in 20 quarters. The position peaked at $9.65M in Q1 2015. 102 funds tracked by Wall St. Rank hold CLDX as of Q2 2018.

  • Teachers Advisors reported no remaining Celldex Therapeutics position as of Q2 2018 after selling out during the quarter.
  • Teachers Advisors sold 67,373 Celldex Therapeutics shares in Q2 2018, an estimated $2.35M.
  • Teachers Advisors first reported a position in Celldex Therapeutics in Q2 2013 and held it in 20 quarters.
  • Teachers Advisors's Celldex Therapeutics position peaked at $9.65M in Q1 2015.
  • 102 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q2 2018.

Based on Teachers Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.